Back
Calidi Biotherapeutics Vs. Lumos Pharma Industry Stock Comparison
Buy
52
CLDI
Calidi Biotherapeutics
Last Price:
2.16
Seasonality Move:
-22.83%
Sell
30
LUMO
Lumos Pharma
Last Price:
4.31
Seasonality Move:
7.61%
Buy
52
Calidi Biotherapeutics (CLDI)
is a Buy
Is Calidi Biotherapeutics a Buy, Sell or Hold?
- The current Calidi Biotherapeutics [CLDI] share price is $2.14. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CLDI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy, Sell or Hold?
- The current Lumos Pharma [LUMO] share price is $4.31. The Score for LUMO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- LUMO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLDI Stock Price Chart
What is Calidi Biotherapeutics's stock price today?
-
The Calidi Biotherapeutics share price today is $2.14
The current trend is moderately bullish and CLDI is experiencing slight buying pressure.
LUMO Stock Price Chart
What is Lumos Pharma's stock price today?
-
The Lumos Pharma share price today is $4.31
The current trend is moderately bullish and LUMO is experiencing selling pressure, which indicates risk of future bearish movement.
CLDI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 56.69 | Buy |
| Chaikin Money Flow: | 734857 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 2.24) | Buy |
| Bollinger Bands (100): | (1.03 - 1.83) | Buy |
LUMO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 54.93 | Buy |
| Chaikin Money Flow: | -113710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.16 - 4.46) | Sell |
| Bollinger Bands (100): | (2.27 - 4.33) | Buy |
CLDI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.36 | Sell |
| 20-day SMA: | 1.8 | Buy |
| 50-day SMA: | 1.38 | Buy |
| 200-day SMA: | 2.71 | Sell |
| 8-day EMA: | 2.18 | Sell |
| 20-day EMA: | 1.9 | Buy |
| 50-day EMA: | 1.6 | Buy |
| 200-day EMA: | 8.19 | Sell |
LUMO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.32 | Sell |
| 20-day SMA: | 4.35 | Sell |
| 50-day SMA: | 4.08 | Buy |
| 200-day SMA: | 3 | Buy |
| 8-day EMA: | 4.33 | Sell |
| 20-day EMA: | 4.29 | Buy |
| 50-day EMA: | 4.02 | Buy |
| 200-day EMA: | 3.33 | Buy |
Calidi Biotherapeutics Earnings Growth & CLDI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.
Lumos Pharma Earnings Growth & LUMO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $2.11 per share.
Calidi Biotherapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lumos Pharma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||